NCT00447876 - Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

January 31, 2009

Study Completion Date

April 30, 2009

Conditions

Chronic Plantar Fasciitis

Interventions

BIOLOGICAL

Botulinum toxin type A

Botulinum type A toxin (Dysport®): 200 Units injected at the root of the plantar fascia

DRUG

Placebo

0.9% sodium chloride: 2 ml injected at the root of the plantar fascia

Trial Locations (6)

University Hospital Charite, Campus Virchow, Musculoskeletal Centre, Orthopedic Clinic, Berlin

Orthopedic Practice Biberburg, Berlin

Orthopedic Practice, Karlsruhe

Orthocentre Munich, Munich

Orthopedic Practice, Weiden

Klinik für Orthopädie und Rheumatologie, Universitätsklinikum Gießen und Marburg GmbH, Marburg